Oral PCSK9 Inhibitors: Will They Work?

被引：0

作者：

Lale Tokgözoğlu ^{[1
]}

Angela Pirillo ^{[2
]}

Alberico L. Catapano ^{[3
]}

机构：

[1] Hacettepe University Medical Faculty,Department of Cardiology

[2] Center for the Study of Atherosclerosis,Center for the Study of Atherosclerosis

[3] E. Bassini Hospital,Department of Pharmacological and Biomolecular Sciences

[4] IRCCS MultiMedica,undefined

[5] University of Milan,undefined

来源：

关键词：

Proprotein convertase subtilisin/kexin type 9; Low-density lipoprotein cholesterol; Lipid-lowering therapy; Oral therapy;

D O I：

10.1007/s11883-025-01299-7

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Oral PCSK9 Inhibitors
Anandita Agarwala
Ramsha Asim
Christie M. Ballantyne
Current Atherosclerosis Reports, 2024, 26 : 147 - 152
[2] Oral PCSK9 Inhibitors
Agarwala, Anandita
Asim, Ramsha
Ballantyne, Christie M.
CURRENT ATHEROSCLEROSIS REPORTS, 2024, 26 (05) : 147 - 152
[3] PCSK9 inhibitors
Farnier, Michel
CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2015, 19 (03): : 66 - 70
[4] PCSK9 inhibitors
Farnier, Michel
CURRENT OPINION IN LIPIDOLOGY, 2013, 24 (03) : 251 - 258
[5] PCSK9 inhibitors
Gencer, Baris
Lambert, Gilles
Mach, Francois
SWISS MEDICAL WEEKLY, 2015, 145
[6] Safety of PCSK9 inhibitors
Grzesk, Grzegorz
Dorota, Bednarska
Wolowiec, Lukasz
Wolowiec, Anna
Osiak, Joanna
Kozakiewicz, Mariusz
Banach, Joanna
BIOMEDICINE & PHARMACOTHERAPY, 2022, 156
[7] Access to PCSK9 Inhibitors
Baum, Seth J.
Lepor, Norman E.
Robinson, Jennifer G.
REVIEWS IN CARDIOVASCULAR MEDICINE, 2018, 19 : S47 - S50
[8] PCSK9 inhibitors are go
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (09) : 593 - 593
[9] PCSK9 inhibitors are go
Asher Mullard
Nature Reviews Drug Discovery, 2015, 14 : 593 - 593
[10] PCSK9 Inhibitors Economics and Policy
Hlatky, Mark A.
Kazi, Dhruv S.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (21) : 2677 - 2687